1620631-21-1

Basic information

• Product Name: 1,1'-[methylenebis(2,4,6-trihydroxy-3,1-phenylene)]bis[3-(4-hydroxyphenyl)propan-1-one]
• Synonyms: 1,1'-[methylenebis(2,4,6-trihydroxy-3,1-phenylene)]bis[3-(4-hydroxyphenyl)propan-1-one]
• CAS NO: 1620631-21-1
• Molecular Weight: 560.557
• Mol File: 1620631-21-1.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 1,1'-[methylenebis(2,4,6-trihydroxy-3,1-phenylene)]bis[3-(4-hydroxyphenyl)propan-1-one](CAS DataBase Reference)
• NIST Chemistry Reference: 1,1'-[methylenebis(2,4,6-trihydroxy-3,1-phenylene)]bis[3-(4-hydroxyphenyl)propan-1-one](1620631-21-1)
• EPA Substance Registry System: 1,1'-[methylenebis(2,4,6-trihydroxy-3,1-phenylene)]bis[3-(4-hydroxyphenyl)propan-1-one](1620631-21-1)

Safety Data

• Hazardous Substances Data: 1620631-21-1(Hazardous Substances Data)

Upstream product

• 60-82-2 3-(4-Hydroxy-phenyl)-1-(2,4,6-trihydroxy-phenyl)-propan-1-on 
• 107-30-2 chloromethyl methyl ether 
• 67-56-1 methanol 
• 60-81-1 phloridizin 

Relevant articles and documents

Novel compound from plasma-treated phloridzin and anti-obesity composition comprising the same as effective component

The present invention relates to a novel compound derived from plasma-treated phloridzin and an anti-obesity composition comprising the same as an effective component and, more specifically, to a diameric compound derived from phloridzin, which is newly formed by plasma-treating phloridzin (methylene-bis-phloridzin, diglucosyl-methylene-bis-phloridzin, and methylene-bis-phloretin), and to an anti-obesity composition comprising the same as an effective component. In particular, the compound derived from phloridzin, comapred to phloridzin, inhibits the activity of pancreatic lipase and enhances the effect of suppressing fat accumulation during differentiation of fat cells. In particular, the methylene-bis-phloretin of the present invention, a diameric body formed by phloretin using a methyl group, a form of which sugars are removed from phloridzin, has excellent inhibitory effect on fat accumlation as compared to phloretin, and thus may be beneficially used as a material for anti-obesity therapeutic agents or anti-obesity functional health foods.COPYRIGHT KIPO 2019